(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.36%) $0.935
(0.67%) $11.02
(0.14%) $0.800
(-0.07%) $92.11
3.92% HKD 0.265
Live Chart Being Loaded With Signals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia...
Stats | |
---|---|
Dagens volum | 4 000.00 |
Gjennomsnittsvolum | 388 433 |
Markedsverdi | 569.76M |
EPS | HKD0 ( 2023-08-28 ) |
Last Dividend | HKD0.00260 ( 2023-06-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -26.50 |
ATR14 | HKD0 (0.00%) |
Tianda Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Tianda Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | HKD532.09M |
Bruttogevinst: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2023 |
Omsetning: | HKD532.09M |
Bruttogevinst: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2022 |
Omsetning: | HKD546.69M |
Bruttogevinst: | HKD251.52M (46.01 %) |
EPS: | HKD-0.0254 |
FY | 2022 |
Omsetning: | HKD509.96M |
Bruttogevinst: | HKD241.22M (47.30 %) |
EPS: | HKD-0.0101 |
Financial Reports:
No articles found.
Tianda Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0112 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.00260 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00450 | 2010-07-23 |
Last Dividend | HKD0.00260 | 2023-06-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.0530 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.23 | -- |
Div. Sustainability Score | 4.25 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 1.955 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9909.HK | Ex Dividend Knight | 2023-11-24 | Semi-Annually | 0 | 0.00% | |
2161.HK | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
1161.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0239.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
3866.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0771.HK | Ex Dividend Junior | 2023-05-31 | Sporadic | 0 | 0.00% | |
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1290.HK | Ex Dividend Junior | 2023-06-14 | Sporadic | 0 | 0.00% | |
0363.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0454 | 1.500 | -0.908 | -1.362 | [0 - 0.5] |
returnOnAssetsTTM | -0.0263 | 1.200 | -0.878 | -1.053 | [0 - 0.3] |
returnOnEquityTTM | -0.0405 | 1.500 | -1.561 | -2.34 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.099 | 0.800 | 9.51 | 7.61 | [1 - 3] |
quickRatioTTM | 0.854 | 0.800 | 9.68 | 7.75 | [0.8 - 2.5] |
cashRatioTTM | 0.518 | 1.500 | 8.23 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.120 | -1.500 | 7.99 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -5.45 | 1.000 | -3.13 | -3.13 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0212 | -0.0424 | [0 - 20] |
debtEquityRatioTTM | 0.187 | -1.500 | 9.25 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.480 | 1.000 | 5.33 | 5.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0545 | 1.000 | -3.09 | -3.09 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.468 | 1.000 | -3.71 | -3.71 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.47 | 7.57 | [0.5 - 2] |
Total Score | 4.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -23.59 | 1.000 | -2.48 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0405 | 2.50 | -1.003 | -2.34 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0141 | -0.0424 | [0 - 30] |
dividendYielPercentageTTM | 0.981 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.156 | 1.500 | -2.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0972 | 1.000 | -4.93 | 0 | [0.1 - 0.5] |
Total Score | -0.341 |
Tianda Pharmaceuticals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.